BME:REN Statistics

Total Valuation

BME:REN has a market cap or net worth of EUR 25.06 million. The enterprise value is 55.43 million.

Market Cap	25.06M
Enterprise Value	55.43M

Important Dates

The next estimated earnings date is Friday, May 2, 2025.

Earnings Date	May 2, 2025
Ex-Dividend Date	n/a

Share Statistics

BME:REN has 32.21 million shares outstanding. The number of shares has increased by 2.79% in one year.

Current Share Class	n/a
Shares Outstanding	32.21M
Shares Change (YoY)	+2.79%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	16.27%
Owned by Institutions (%)	4.58%
Float	19.19M

Valuation Ratios

The trailing PE ratio is 7.78.

PE Ratio	7.78
Forward PE	n/a
PS Ratio	1.00
PB Ratio	0.42
P/TBV Ratio	0.42
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.45, with an EV/FCF ratio of -24.71.

EV / Earnings	16.76
EV / Sales	2.16
EV / EBITDA	6.45
EV / EBIT	6.88
EV / FCF	-24.71

Financial Position

The company has a current ratio of 1.36, with a Debt / Equity ratio of 0.42.

Current Ratio	1.36
Quick Ratio	0.24
Debt / Equity	0.42
Debt / EBITDA	3.27
Debt / FCF	-12.54
Interest Coverage	2.70

Financial Efficiency

Return on equity (ROE) is 6.50% and return on invested capital (ROIC) is 5.39%.

Return on Equity (ROE)	6.50%
Return on Assets (ROA)	4.78%
Return on Invested Capital (ROIC)	5.39%
Return on Capital Employed (ROCE)	9.92%
Revenue Per Employee	598,093
Profits Per Employee	76,907
Employee Count	43
Asset Turnover	0.24
Inventory Turnover	0.52

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +1.07% in the last 52 weeks. The beta is 1.07, so BME:REN's price volatility has been similar to the market average.

Beta (5Y)	1.07
52-Week Price Change	+1.07%
50-Day Moving Average	0.78
200-Day Moving Average	0.75
Relative Strength Index (RSI)	47.09
Average Volume (20 Days)	24,270

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, BME:REN had revenue of EUR 25.72 million and earned 3.31 million in profits. Earnings per share was 0.10.

Revenue	25.72M
Gross Profit	13.08M
Operating Income	8.06M
Pretax Income	4.95M
Net Income	3.31M
EBITDA	8.59M
EBIT	8.06M
Earnings Per Share (EPS)	0.10

Full Income Statement

Balance Sheet

The company has 4.47 million in cash and 28.13 million in debt, giving a net cash position of -23.66 million or -0.73 per share.

Cash & Cash Equivalents	4.47M
Total Debt	28.13M
Net Cash	-23.66M
Net Cash Per Share	-0.73
Equity (Book Value)	67.46M
Book Value Per Share	1.84
Working Capital	9.06M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.34 million and capital expenditures -3.58 million, giving a free cash flow of -2.24 million.

Operating Cash Flow	1.34M
Capital Expenditures	-3.58M
Free Cash Flow	-2.24M
FCF Per Share	-0.07

Full Cash Flow Statement

Margins

Gross margin is 50.85%, with operating and profit margins of 31.34% and 12.86%.

Gross Margin	50.85%
Operating Margin	31.34%
Pretax Margin	19.25%
Profit Margin	12.86%
EBITDA Margin	33.40%
EBIT Margin	31.34%
FCF Margin	n/a

Dividends & Yields

BME:REN does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-2.79%
Shareholder Yield	-2.79%
Earnings Yield	13.20%
FCF Yield	-8.95%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BME:REN has an Altman Z-Score of -0.05. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-0.05
Piotroski F-Score	n/a